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Background/aim: Mediastinoscopy is an invasive procedure that is used in the diagnosis of mediastinal diseases and in staging lung
cancer. Tumor cell seeding during mediastinoscopy along the mediastinum and the incision line is a very rare complication. This study
aimed to test the safety of mediastinoscopy in terms of tumor seeding by cytological evaluation of mediastinal lavage samples taken
before and after biopsy.
Materials and methods: The patients who underwent mediastinoscopy in our hospital between 2011 and 2014 were studied prospectively.
Seventy-three patients with a diagnosis of lung or mediastinal malignancy were included in the study. All patients underwent classical
cervical mediastinoscopy and mediastinal lavages were taken before and after the biopsy. Both lavage samples were sent to the pathology
department in syringes for malignant cell cytology screening.
Results: The results of the histopathological examinations of lymph node biopsies were reactive in 25 patients and positive for malignancy
in 48 patients. In 2 of 48 patients whose lymph nodes were reported to be positive for malignancy, the mediastinal lavage sample was
reported to be positive for malignancy after biopsy, although it was negative preoperatively. In two patients, both the pre- and postbiopsy
lavage samples were reported to be positive for malignancy.
Conclusion: While performing dissection and biopsy during mediastinoscopy, tumor seeding into the mediastinum may occur. Long
follow-up periods and large patient series are needed to determine how cytopathological examination of both fluids would affect the
prognosis.
Key words: Mediastinoscopy, lavage, cytology

1. Introduction
Mediastinoscopy is an invasive procedure used in the
diagnosis of mediastinal diseases and in staging lung
cancer. A mediastinoscopy performed safely and effectively
not only increases the percentage of correct diagnosis
but also minimizes the complication rate (1). Tumor cell
seeding during mediastinoscopy along the mediastinum
and the incision line is a very rare complication.
This study aimed to test the safety of mediastinoscopy
in terms of tumor seeding by the cytological evaluation of
mediastinal lavage samples taken before and after biopsy.
2. Materials and methods
The patients who underwent mediastinoscopy in our
hospital between 2011 and 2014 were studied prospectively.
Of these mediastinoscopies, some were performed for
staging lung cancer and some were performed for the
diagnosis of mediastinal lymphadenopathy. Seventy-three
* Correspondence: yaseminbuyukkarabacak@gmail.com
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patients with a diagnosis of lung or mediastinal malignancy
were included in the study. Patients with tuberculosis and
sarcoidosis were excluded. All patients were evaluated with
thorax tomography and positron emission tomography
(PET). In all patients, mediastinal lavage was taken before
and after the biopsy.
All
patients
underwent
classical
cervical
mediastinoscopy. After placing a mediastinoscope into
the mediastinum, the subcarinal region was reached with
a blunt and sharp dissection along the midline without
exploring the lymph nodes. A 14-gauge feeding tube was
placed into the mediastinum through the mediastinoscope.
The mediastinum was washed with 20 mL of physiological
saline solution given through this tube, and lavage was
taken. The mediastinoscope was then pulled upward and
the right, left, upper, and lower paratracheal, subcarinal,
and antecarinal regions were evaluated. Biopsies were
taken from all explored lymph glands. After the biopsy
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procedures, the mediastinoscope was advanced into
the subcarinal region again. While it was being pulled
upward, the lavage procedure was repeated by washing the
mediastinum with 20 mL of physiological saline solution.
Both lavage samples were sent to the pathology
department in syringes for malignant cell cytology
screening. The aspirated washing fluid was immediately
sent to the cytopathology laboratory without performing
fixation. The quantity and properties of the received fluids
were recorded by the laboratory. Cytocentrifuge and
direct use of the sediment were the preferred methods for
these fluids with low cell and protein content. The fluid
was cytocentrifuged in a Liquid Shandon Cytospin III
cytocentrifuge device (Thermo Scientific, USA) at 1500
rpm for 10 min. The supernatant was removed with a
Pasteur pipette, and the remaining sediment was used.
Four slides were prepared with the drops taken from
this sediment. Three of these slides were immediately
fixed with 95% ethyl alcohol for 15 min and stained with
Papanicolaou (PAP) stain. One was air dried for 15 min
and stained with Diff-Quik, and then all were closed with
lamella. In bloody fluids, an equal amount of physiological
saline solution was added to the fluid, and initial
centrifugation was performed. All samples were studied by
a pathologist experienced in cytology and were classified
as ‘positive’, ‘doubtful’, and ‘negative’.
3. Results
Of the patients, 30 were female and 43 were male. The
mean age was 63.4 years (range: 37‒76 years). The
primary diagnosis was small cell lung cancer in 6 patients,
epidermoid carcinoma in 30 patients, adenocarcinoma in
22 patients, lymphoma in 10 patients, carcinoma in situ in
1 patient, vaginal malignant melanoma in 1 patient, renal
cell carcinoma in 1 patient, skin squamous cell carcinoma
in 1 patient, and papillary thyroid carcinoma in 1 patient
(Figure 1).
Primary Diagnoses
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4. Discussion
In patients with lung cancer, correct staging achieved
by evaluating the size of the tumor, the regional lymph
nodes, and the presence of metastases is crucial. In
the absence of remote metastasis, the evaluation of the
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Since there are no established criteria for mediastinal
fluid, all samples containing cellular elements were
included in the study. Although small, there was an
increase in the number of mesothelial and inflammatory
cells in lavages after biopsy. In 2 patients, tumor cells were
detected in both pre- and postbiopsy lavage fluids. In 2
patients, although there were only a few inflammatory cells
in prebiopsy lavage fluid, malignant cells were detected
in postbiopsy lavage fluid. In the rest of the patients, no
malignant cells were observed in pre- or postbiopsy lavage
fluids. (Figures 2 and 3) There were no washing fluid
samples with mediastinitis.
While the most sampled lymph node in patients was the
right lower paratracheal lymph node, the least sampled one
was the left upper paratracheal lymph node. The numbers
of the sampled lymph node stations are given in Figure 4.
The results of the histopathological examinations of lymph
node biopsies were reactive in 25 patients and positive for
malignancy in 48 patients. In 2 of the 48 patients whose
lymph nodes were reported to be positive for malignancy,
the mediastinal lavage sample was reported to be positive
for malignancy after biopsy, although it was negative
preoperatively. In two patients, both the pre- and postbiopsy
lavage samples were reported to be positive for malignancy
(Figures 5 and 6). Biopsy samples were taken from right
lymph nodes 2, 4, and 7 in two patients, and in the other
two, they were taken from the lung-originated masses
invasive to the mediastinum. Primary diagnosis was small
cell lung carcinoma in 1 patient, lung adenocarcinoma in
2, and epidermoid lung cancer in 1. No procedure-related
morbidity or mortality was observed.

Lymphoma
CIS (Lung)
MM
RCC
Skin SCC
Papillary thyroid carcinoma

Figure 1. Primary diagnoses.
SCLC: Small cell lung cancer, SCC: squamous cell carcinoma, PAC: pulmonary
adenocarcinoma, CIS: carcinoma in situ (lung), MM: malignant melanoma,
RCC: renal cell carcinoma.
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Figure 2. Images of a patient with positive postbiopsy lavage
a) before biopsy and b) after biopsy.

Figure 5. Right no. 4 lymph node (postbiopsy mediastinal lavage
“malignancy +”).
Figure 3. Malignant cells in the washing liquid a) before biopsy
and b) after biopsy (PAP staining, magnification: 1000×).
Lymph node situations and histopathological features
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Figure 4. Lymph node stations and histopathological features.
2R: Upper right paratracheal lymph nodes, 2L: upper left
paratracheal lymph nodes, 4R: lower right paratracheal lymph
nodes, 4L: lower left paratracheal lymph nodes, 7: subcarinal
lymph nodes, MM: lung-originated mediastinal mass.

status of regional lymph nodes is the main factor in
determining the treatment method. Furthermore, in
patients with malignant mediastinal lymph nodes detected
in the preoperative examination, choosing multimodal
treatments contributes greatly to an improved prognosis.
Therefore, the evaluation of the status of the mediastinal
lymph nodes preoperatively and after induction therapies
is very important (2).
The main noninvasive radiological diagnostic method
used to evaluate the mediastinum is computed tomography
(CT). However, in many studies in the literature, it has
been reported that CT is limited in staging the lymph
nodes (3,4). Furthermore, while lymph nodes smaller
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Figure 6. Left no. 4 lymph node (pre- and postbiopsy mediastinal
lavage “malignancy +”).

than 1 cm in CT can be positive for malignancy, the larger
lymph nodes can be negative. Thus, taking the lymph node
size as a benchmark is not a proper approach in staging
lung tumors (5). In a series of 100 patients with nonsmall
cell lung cancer who underwent mediastinoscopy, Gdeedo
et al. reported that the sensitivity and specificity of
mediastinoscopy were 89% and 100%, respectively, while
they were 63% and 57% in CT (6). In our series, although
the lymph nodes were smaller than 1 cm in 10 of the 48
patients with positive mediastinal lymph nodes, they were
positive for malignancy in histopathological evaluation.
On the other hand, in 5 patients with lymph nodes larger
than 1 cm, the lymph nodes were negative for malignancy.
Today, the PET imaging method with F-18 fluoro-2deoxy-D-glucose (FDG) is commonly used in staging
mediastinal lymph nodes. The biological activity of
the tumor can be determined by this method. In many
metaanalyses in the literature, it has been demonstrated that
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PET is significantly superior to CT in staging mediastinal
lymph nodes. However, in PET, the accurate evaluation of
FDG uptake is possible only when the size of the lymph
node is greater than 1 cm (7‒9). Additionally, the evaluation
of histopathological and immunological features is more
important than the evaluation of radiological features in
determining the appropriate treatment method. Because of
all these mentioned reasons and despite the new methods
developed in recent years (PET-CT, endobronchial
ultrasound-guided transbronchial needle aspiration, or
endoscopic ultrasound-guided fine-needle aspiration),
mediastinoscopy is still considered the “gold standard” in
mediastinal staging of lung cancer (10,11).
The factors limiting the safety of mediastinoscopy and
increasing the rate of complications are: 1) it is an invasive
method, 2) it requires general anesthesia, 3) not all lymph
node stations can be reached, 4) cervical goiters, 5)
presence of permanent tracheostomy after laryngectomy
and/or radiotherapy, and 6) a previously performed
mediastinoscopy (12). In our series, large thyroid glands
were detected in 12 patients. Therefore, the thyroid gland
was dissected at the midline and pulled up to perform the
procedure. Except for this problem, no other problems
that would cause technical difficulties were encountered.
Morbidity and mortality after mediastinoscopy is rare.
In the literature, morbidity and mortality rates are reported
as 0.08% and 0%, respectively. Abundant bleeding,
tracheobronchial laceration, esophageal perforation,
recurrent nerve paralysis, phrenic nerve paralysis, thoracic
duct injury, mediastinitis, venous air embolism, and tumor
cell seeding along the mediastinum and incision line
implantation have been reported as major complications
(12). In our patients, none of the major complications
were observed. However, in 2 patients, malignant cells
were observed in both the predissection and postbiopsy
mediastinal lavage fluids, and in 2 patients only in the
postbiopsy lavage fluid. In 2 of these patients, biopsy
samples were taken from lung-originated mediastinal
masses, whereas they were taken from lower paratracheal
and subcarinal lymph nodes in the other two.
Dissection is essential in all phases of mediastinoscopy
for exploration and biopsy. Cellular seeding into the
mediastinum may occur during dissection or biopsy
procedures (13). In the literature, the incidence of tumor
seeding after mediastinoscopy is reported to be 0.12%
along the entire incision line down to the mediastinum.
In the metaanalysis of a study including 6490 patients who
underwent cervical mediastinoscopy, tumor cells along
the incision line were detected only in 8 patients (14).
The mechanism of tumor seeding during
mediastinoscopy is not known in full. The most likely
explanation is considered to be the direct seeding of
the tumor cells into the mediastinum during biopsy.

However, this theory could not explain the mechanism
of the metastasis in patients whose mediastinoscopies are
negative but who have tumors in the incision line. In the
early recovery period, excessive blood build up is observed
along the incision and dissection lines. It is considered
that in these patients, the increased hematogenous or
lymphogenic flow transports the tumor cells into the
mediastinum and incision line (15).
The number of stage 3 lung cancer patients with
incisional tumor metastasis is very limited in the literature.
Two of these were reported to have adenocarcinoma, 2
epidermoid carcinoma, 1 small cell adenocarcinoma,
and 1 large cell adenocarcinoma. It is understood that
the development of metastasis along the incision and
dissection lines are independent of the pathological type
of the tumor and the degree of the cellular differentiation.
Additionally, it is not clear if it is related to the stage of the
tumor or not. In 4 of these patients, tumors were reported
to be stage 3a, whereas in one it was stage 2a and in one
the stage was indefinable. In our series, all patients were
defined as having stage 3b lung cancer. As the number of
positive lymph node stations and biopsies increase, and
as the dissections go deeper, there may be an increase in
the incidence of tumor seeding (15‒18). In our series, in
2 of the patients with positive mediastinal lavage, biopsy
samples were taken from lymph node stations 2, 4, and
7; in the other 2, the samples were taken from the lungoriginated masses invasive into the mediastinum.
In the literature, there are numerous studies
investigating the relation between pleural lavage fluid
cytology and survival in lung tumors (19). However, no
data about the cytological examination of the mediastinal
lavage fluid could be found in the literature. Thus, we
believe that “presence of any kind of cellular elements in
prebiopsy washings” and “presence of several mesothelial
cells in the postbiopsy samples” can be the criteria for
defining the suitability of the lavage fluid. Although no
operation was performed in 2 patients, their first lavage
fluids contained malignant cells. This could be a remarkable
finding indicating a poor prognosis. Of these patients, one
died in the first postoperative month; the other patient
was still alive at month 16. Scattering of the free tumor
cells is an expected situation. In our series, mediastinal
lavage fluid was found to be positive after the operation in
2 patients. Both of the patients died within 2 postoperative
years. Whether or not these positive results could be
accepted as clues for tumor seeding can only be clarified
by this phenomenon itself. The pleural washing studies in
the literature reported that survival decreases in patients
with preoperative negative but postoperative positive
pleural fluid. However, we still do not have enough data to
determine the effects of cytologically positive mediastinal
lavage fluid on the prognosis and risk of recurrence.
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In conclusion, mediastinoscopy is an invasive
diagnostic method with high effectiveness and low
morbidity and mortality. During cervical mediastinoscopic
biopsy, cellular tumor seeding into the mediastinum is
a rare complication. However, it should be kept in mind
that while performing dissection and biopsy, particularly
in the presence of multistation lymph nodes or lung

tumors invasive into the mediastinum, tumor seeding
into the mediastinum may occur. Long follow-up periods
and large patient series are needed to determine how
mediastinal washing before and after the mediastinoscopy
and cytopathological examination of both fluids would
affect the prognosis.
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